United States Pharmaceuticals

Innovus Pharmaceuticals Inc (INNV)

Track

Ticker: INNV Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
426.60
Quantity 25,428
Value US$4,598,700
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
326.28
Quantity 31,954 -14.9%
Value US$3,537,541
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
231.08
Quantity 10,433
Value US$4,148,423
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
2.48
Quantity 9,183 +3.3%
Value US$22,774
ESBER HENRY JEMIL
Transaction date
Purchase
Price
0.10
Quantity 5,000 +5.3%
Value US$488
ESBER HENRY JEMIL
Transaction date
Purchase
Price
0.09
Quantity 5,000 +5.6%
Value US$470
ESBER HENRY JEMIL
Transaction date
Purchase
Price
0.09
Quantity 90,000 +inf%
Value US$8,334
Berholtz Randy EVP, CORPORATE DEVELOPMENT
Transaction date
Purchase
Price
0.10
Quantity 2,000 +13.4%
Value US$191
Berholtz Randy EVP, CORPORATE DEVELOPMENT
Transaction date
Purchase
Price
0.10
Quantity 4,990 +50.5%
Value US$483
Berholtz Randy EVP, CORPORATE DEVELOPMENT
Transaction date
Purchase
Price
0.10
Quantity 4,900 +98.2%
Value US$474
Berholtz Randy EVP, CORPORATE DEVELOPMENT
Transaction date
Purchase
Price
0.10
Quantity 4,990 +inf%
Value US$483
Damaj Bassam President & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.32
Quantity 129,393 +inf%
Value US$41,794
Damaj Bassam President & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.32
Quantity 287,448 +6.0%
Value US$92,846
Damaj Bassam President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.48
Quantity 250,406 +inf%
Value US$118,993
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-09-18 2019-09-17 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
25,428
426.60
US$4,598,700 		25,428 426.60 US$4,598,700
2019-09-18 2019-09-17 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
31,954 -14.9%
326.28
US$3,537,541 		31,954 -14.9% 326.28 US$3,537,541
2019-09-18 2019-09-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
10,433
231.08
US$4,148,423 		10,433 231.08 US$4,148,423
2019-09-18 2019-09-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
9,183 +3.3%
2.48
US$22,774 		9,183 +3.3% 2.48 US$22,774
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
5,000 +5.3%
0.10
US$488 		5,000 +5.3% 0.10 US$488
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
5,000 +5.6%
0.09
US$470 		5,000 +5.6% 0.09 US$470
2017-11-27 2017-11-23 B Purchase ESBER HENRY JEMIL
90,000 +inf%
0.09
US$8,334 		90,000 +inf% 0.09 US$8,334
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
2,000 +13.4%
0.10
US$191 		2,000 +13.4% 0.10 US$191
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,990 +50.5%
0.10
US$483 		4,990 +50.5% 0.10 US$483
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,900 +98.2%
0.10
US$474 		4,900 +98.2% 0.10 US$474
2017-11-27 2017-11-22 B Purchase Berholtz Randy

EVP, CORPORATE DEVELOPMENT
4,990 +inf%
0.10
US$483 		4,990 +inf% 0.10 US$483
2013-06-14 2013-06-12 B Purchase Damaj Bassam

President & CEO

Executive Director Large shareholder
129,393 +inf%
0.32
US$41,794 		129,393 +inf% 0.32 US$41,794
2013-06-14 2013-06-12 B Purchase Damaj Bassam

President & CEO

Executive Director Large shareholder
287,448 +6.0%
0.32
US$92,846 		287,448 +6.0% 0.32 US$92,846
2013-02-05 2013-02-02 B Purchase Damaj Bassam

President and CEO

Executive Director Large shareholder
250,406 +inf%
0.48
US$118,993 		250,406 +inf% 0.48 US$118,993
Explore more

More insider trading research around Innovus Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America